LithiumBank Resources

22ND CENTURY GROUP (NASDAQ: XXII) STOCK QUOTE

Last Trade: US$1.68 0.08 5.00
Volume: 943,713
5-Day Change: 13.51%
YTD Change: 802.26%
Market Cap: US$4.570M

LATEST NEWS FROM 22ND CENTURY GROUP

Pinnacle Branded Products Growing At Over 10% at Top-5 U.S. C-Store Chain Mocksville, North Carolina--(Newsfile Corp. - April 11, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today announced that it has expanded its Pinnacle private label brand to add distribution of cigarillo products to its existing Pinnacle cigarette products. Pinnacle products are... Read More
Company Bolsters Balance Sheet with $4.2 Million Capital Infusion New Senior Leadership Team Announced to Further Drive Shareholder Value Mocksville, North Carolina--(Newsfile Corp. - April 8, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today announced that it has entered into a binding letter of agreement with its senior secured lender, intended to... Read More
New Contract Will Commence in Second Quarter, Ultimately Boost CMO Volumes by More Than 20% Mocksville, North Carolina--(Newsfile Corp. - April 4, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today announced that it has signed a significant new contract manufacturing agreement for the production of branded conventional cigarette products. The contract, which... Read More
Mocksville, North Carolina--(Newsfile Corp. - March 28, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today reported results for the fourth quarter ended December 31, 2023, and provided an update on recent business highlights. Fourth quarter results and recent business activities included: Net revenue from continuing operations in the fourth quarter of 2023... Read More
Mocksville, North Carolina--(Newsfile Corp. - March 15, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco company focused on tobacco harm reduction to improve smoker health and wellness, will host a live webcast on Thursday, March 28, 2024, at 8:00 AM ET to discuss its 2023 fourth quarter results, which are to be reported in a press release at 6:00 AM ET the same day. During the webcast, Larry Firestone, chairman... Read More
Reduced Cost Structure Expected to Save more than $1Million Annually in 2024, Aligns Board with Corporate-Wide Lean Operating Commitment Mocksville, North Carolina--(Newsfile Corp. - February 13, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII) (the "Company" or "22nd Century"), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced a reduction in board... Read More
Mocksville, North Carolina--(Newsfile Corp. - February 6, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII) (the "Company" or "22nd Century"), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced that the Company will present at the Emerging Growth Conference on February 8, 2024. Larry Firestone, Chairman and Chief Executive Officer, will present as part of an... Read More
Transforming Business into Lean Operating Base, Extending Cash Runway, Shareholder Meeting to Re-convene February 15 Mocksville, North Carolina--(Newsfile Corp. - January 24, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII) (the "Company" or "22nd Century"), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced that the Company conducted its January 24, 2024... Read More
Fireside Chat Webcast Event to Take Place January 17, 2024 Buffalo, New York--(Newsfile Corp. - January 17, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII) (the "Company" or "22nd Century"), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today provided a shareholder update. "I am pleased with the progress of the company since assuming my role as Chairman and Chief... Read More
Analyst Hosted Event to Discuss Refocused Business, Cost Reductions and Turnaround Plan Buffalo, New York--(Newsfile Corp. - January 12, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII) (the "Company" or "22nd Century"), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced that it will host a fireside chat event on Wednesday, January 17, 2024 beginning at... Read More
Sale Will Significantly Reduce Operating Expenses, Ultimately Reduce Debt by $5.2 Million Buffalo, New York--(Newsfile Corp. - December 28, 2023) - 22nd Century Group, Inc. (NASDAQ: XXII) (the "Company" or "22nd Century"), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced it has closed the sale of its hemp/cannabis operations. The transaction will... Read More
Sale and Related Actions Ultimately Expected to Reduce Debt Principal by $5.2 Million Buffalo, New York--(Newsfile Corp. - December 14, 2023) - 22nd Century Group, Inc. (NASDAQ: XXII) (the "Company" or "22nd Century"), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced it has secured the consent of its senior lender under the terms of its Senior Secured... Read More
Pinnacle Cigarette Brand to Be Sold in up to 1,700 U.S. Retail Locations in up to 27 States Dramatically Increases CDMO Revenue and Business Unit Profitability Toward Cash Positive, in Line with Recent Expectations Buffalo, New York--(Newsfile Corp. - April 18, 2023) - 22nd Century Group, Inc. (NASDAQ: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops... Read More
Two of the Largest U.S. Convenience Store Distributors Will Support VLN® Rollout into New States and Regions Expects Multiple Retail Chain Customers of Core-Mark and Eby-Brown to Carry 22nd Century's VLN® Cigarettes Buffalo, New York--(Newsfile Corp. - January 18, 2023) - 22nd Century Group, Inc. (Nasdaq: XXII), the world's leading biotechnology company dedicated to improving health with reduced nicotine tobacco and advanced... Read More
Proposed Menthol Ban Could Leave 22nd Century's VLN® Menthol King as the Only Menthol Cigarette in the $26 Billion U.S. Menthol Market FDA to Advance Reduced Nicotine Content Standards for All Combustible Cigarettes in Q4 2023 Paradigm Shift in Tobacco Health Policy and Regulation Expected to Generate Major Gains for Public Health Buffalo, New York--(Newsfile Corp. - January 17, 2023) - 22nd Century Group, Inc. (NASDAQ:... Read More
NEW YORK, NY / ACCESSWIRE / December 16, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies recently issued a new C-Level interview with 22nd Century Group. Toni had the pleasure of recently conducting the Interview with John Miller President, 22nd Century Group Inc. (NASDAQ:XXII). Toni diligently focused on questions she thought... Read More
Committed to Supporting New Zealand's Reduced Nicotine Law with Its Tobacco Biotechnology New Law Represents Significant Opportunity to Improve National Health through Well Designed Public Policy Framework Believes New Zealand Law Provides a Template for Similar Action in Other Countries, Including the United States Buffalo, New York--(Newsfile Corp. - December 13, 2022) - 22nd Century Group, Inc. (NASDAQ: XXII), a leading... Read More
Customer shipments continue uninterrupted, expects to resume production within weeks Buffalo, New York--(Newsfile Corp. - December 8, 2022) - GVB Biopharma , a 22nd Century Group company (NASDAQ: XXII), today provided updates on its operational recovery progress and customer shipments following a fire that occurred at its distillate and isolate manufacturing facility located in Grass Valley, Oregon, on November 20, 2022. The... Read More
GVB Biopharma , a 22nd Century Group company (NASDAQ: XXII), today announced that a fire occurred at its GVB Biopharma distillate and isolate manufacturing facility located in Grass Valley, Oregon, on November 20, 2022. There were no reported life threatening injuries, but the fire damaged the facility. "We want to thank the first responders who were able to quickly contain the fire and prioritize the safety of local... Read More

COPYRIGHT ©2022 GREEN STOCK NEWS